Stay updated on Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FPwOi4udGo_ct9KUrdrLYQmU6yd4.uncropped.jpg&w=3840&q=75)
Latest updates to the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page
- ChecktodayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version 2.10.0, adding two more study numbers and indicating that the study now has 10 locations, while the previous version 2.9.7 has been removed.SummaryDifference0.5%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more Revision: v2.9.0' has recently changed to 'MedlinePlus related topics: COVID-19 (Coronavirus Disease 2019) FDA Drug and Device Resources'. This change indicates an update related to COVID-19 resources and information.SummaryDifference74%
Stay in the know with updates to Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.